Before taking its repurposed diabetes drug candidate into a phase 2 lupus trial, Conduit Pharmaceuticals is tapping Charles ...
3d
News Medical on MSNInsilico Medicine announces preclinical drug discovery benchmarks from 2021 to 2024Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...
The company states the acquisition will further MERIT’s service offerings, allowing for a seamless transition from ...
SIL-204 showed synergistic efficacy with 5-fluorouracil, irinotecan and gemcitabine in preclinical models of pancreatic cancer. ZSilexion plans Phase 2/3 trials for SIL-204 in 2026 and raised $5 ...
(RTTNews) - CytoDyn Inc. (CYDY.OB) has announced positive results from its preclinical studies in collaboration with SMC Laboratories, demonstrating the potential of leronlimab to reverse liver ...
The Phase I trial conducted concurrently in ... guided by Chemistry42's structure-based drug design strategy. In preclinical studies, ISM6331 demonstrated broad anti-tumor efficacy in multiple ...
The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results